113 related articles for article (PubMed ID: 27253461)
1. MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.
Lohkamp LN; Schinz M; Gehlhaar C; Guse K; Thomale UW; Vajkoczy P; Heppner FL; Koch A
PLoS One; 2016; 11(6):e0156422. PubMed ID: 27253461
[TBL] [Abstract][Full Text] [Related]
2. Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
Xi S; Jiang S; Li H; Huang Q; Lu J; Zhang X; Li Z; Zeng J
Int J Cancer; 2024 Jul; 155(1):172-183. PubMed ID: 38411299
[TBL] [Abstract][Full Text] [Related]
3. Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases.
Aisner DL; Newell KL; Pollack AG; Kleinschmidt-Demasters BK; Steinberg GK; Smyth LT; Vogel H
Clin Neuropathol; 2014; 33(2):112-21. PubMed ID: 24321241
[TBL] [Abstract][Full Text] [Related]
4. The Significance of
Prieto R; Barrios L; Ebrat-Mancilla E; Martín P; Tejerina E
Int J Surg Pathol; 2024 Jun; 32(4):649-666. PubMed ID: 37743598
[TBL] [Abstract][Full Text] [Related]
5. Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases.
Vizcaino MA; Giannini C; Lalich D; Nael A; Jenkins RB; Tran Q; Orr BA; Abdullaev Z; Aldape K; Vaubel RA
J Neuropathol Exp Neurol; 2024 May; 83(6):416-424. PubMed ID: 38699943
[TBL] [Abstract][Full Text] [Related]
6. Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations.
Wang AC; Jones DTW; Abecassis IJ; Cole BL; Leary SES; Lockwood CM; Chavez L; Capper D; Korshunov A; Fallah A; Wang S; Ene C; Olson JM; Geyer JR; Holland EC; Lee A; Ellenbogen RG; Ojemann JG
Mol Cancer Res; 2018 Oct; 16(10):1491-1498. PubMed ID: 30006355
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E in a preclinical model of pleomorphic Xanthoastrocytoma: Analysis of the tumor microenvironment and immune cell infiltration dynamics
Canella A; Nazzaro M; Artomov M; Rao Venkata LP; Thomas D; Lyberger J; Ukhatov A; Xing YL; Miller K; Behbehani G; Amankulor NM; Petritsch CK; Rajappa P
Mol Ther Oncol; 2024 Jun; 32(2):200808. PubMed ID: 38784952
[TBL] [Abstract][Full Text] [Related]
8. Rare
Chau L; Nael A; Sato M; Crawford JR
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38238163
[No Abstract] [Full Text] [Related]
9. ATRX immunostaining predicts IDH and H3F3A status in gliomas.
Ebrahimi A; Skardelly M; Bonzheim I; Ott I; Mühleisen H; Eckert F; Tabatabai G; Schittenhelm J
Acta Neuropathol Commun; 2016 Jun; 4(1):60. PubMed ID: 27311324
[TBL] [Abstract][Full Text] [Related]
10. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.
Mandel JJ; Cachia D; Liu D; Wilson C; Aldape K; Fuller G; de Groot JF
J Neurooncol; 2016 Aug; 129(1):147-54. PubMed ID: 27270908
[TBL] [Abstract][Full Text] [Related]
11. The whole-genome landscape of medulloblastoma subtypes.
Northcott PA; Buchhalter I; Morrissy AS; Hovestadt V; Weischenfeldt J; Ehrenberger T; Gröbner S; Segura-Wang M; Zichner T; Rudneva VA; Warnatz HJ; Sidiropoulos N; Phillips AH; Schumacher S; Kleinheinz K; Waszak SM; Erkek S; Jones DTW; Worst BC; Kool M; Zapatka M; Jäger N; Chavez L; Hutter B; Bieg M; Paramasivam N; Heinold M; Gu Z; Ishaque N; Jäger-Schmidt C; Imbusch CD; Jugold A; Hübschmann D; Risch T; Amstislavskiy V; Gonzalez FGR; Weber UD; Wolf S; Robinson GW; Zhou X; Wu G; Finkelstein D; Liu Y; Cavalli FMG; Luu B; Ramaswamy V; Wu X; Koster J; Ryzhova M; Cho YJ; Pomeroy SL; Herold-Mende C; Schuhmann M; Ebinger M; Liau LM; Mora J; McLendon RE; Jabado N; Kumabe T; Chuah E; Ma Y; Moore RA; Mungall AJ; Mungall KL; Thiessen N; Tse K; Wong T; Jones SJM; Witt O; Milde T; Von Deimling A; Capper D; Korshunov A; Yaspo ML; Kriwacki R; Gajjar A; Zhang J; Beroukhim R; Fraenkel E; Korbel JO; Brors B; Schlesner M; Eils R; Marra MA; Pfister SM; Taylor MD; Lichter P
Nature; 2017 Jul; 547(7663):311-317. PubMed ID: 28726821
[TBL] [Abstract][Full Text] [Related]
12. WHO 2016 Classification of gliomas.
Wesseling P; Capper D
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
[TBL] [Abstract][Full Text] [Related]
13. Molecular alterations in pediatric brainstem gliomas.
Porkholm M; Raunio A; Vainionpää R; Salonen T; Hernesniemi J; Valanne L; Satopää J; Karppinen A; Oinas M; Tynninen O; Pentikäinen V; Kivivuori SM
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792659
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
[TBL] [Abstract][Full Text] [Related]
15. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
Phillips JJ; Gong H; Chen K; Joseph NM; van Ziffle J; Bastian BC; Grenert JP; Kline CN; Mueller S; Banerjee A; Nicolaides T; Gupta N; Berger MS; Lee HS; Pekmezci M; Tihan T; Bollen AW; Perry A; Shieh JTC; Solomon DA
Brain Pathol; 2019 Jan; 29(1):85-96. PubMed ID: 30051528
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Utility of Immunohistochemical Detection of MEOX2, SOX11, INSM1 and EGFR in Gliomas.
Soukup J; Gerykova L; Rachelkar A; Hornychova H; Bartos MC; Krupa P; Vitovcova B; Pleskacova Z; Kasparova P; Dvorakova K; Skarkova V; Petera J
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568909
[TBL] [Abstract][Full Text] [Related]
17. Clinical, Morphological, and Molecular Study on Grade 2 and 3 Pleomorphic Xanthoastrocytoma.
Zhang H; Ma XJ; Xiang XP; Wang QY; Tang JL; Yu XY; Xu JH
Curr Oncol; 2023 Feb; 30(2):2405-2416. PubMed ID: 36826144
[TBL] [Abstract][Full Text] [Related]
18. Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status.
Bader JM; Deigendesch N; Misch M; Mann M; Koch A; Meissner F
Cell Rep Med; 2023 Jan; 4(1):100877. PubMed ID: 36584682
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature.
Detti B; Scoccianti S; Maragna V; Lucidi S; Ganovelli M; Teriaca MA; Caini S; Desideri I; Agresti B; Greto D; Buccoliero AM; Puppa AD; Sardi I; Livi L
Radiol Med; 2022 Oct; 127(10):1134-1141. PubMed ID: 35951279
[TBL] [Abstract][Full Text] [Related]
20. High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts.
Roux A; Pallud J; Saffroy R; Edjlali-Goujon M; Debily MA; Boddaert N; Sanson M; Puget S; Knafo S; Adam C; Faillot T; Cazals-Hatem D; Mandonnet E; Polivka M; Dorfmüller G; Dauta A; Desplanques M; Gareton A; Pages M; Tauziede-Espariat A; Grill J; Bourdeaut F; Doz F; Dhermain F; Mokhtari K; Chretien F; Figarella-Branger D; Varlet P
Neuro Oncol; 2020 Aug; 22(8):1190-1202. PubMed ID: 32025728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
